相关实验视频

Updated: Jun 7, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

基于FAERS数据库的SACITUSUZUMABGOVITECAN药物不良事件的挖掘和影响因素分析

Liu Yang^1,2, Xueyu Duan³, Shilin Wu⁴

¹College of Pharmacy, Dali University, Dali, Yunnan, China.

Expert opinion on drug safety

|November 19, 2024

概括

这项研究使用FAERS数据分析了sacituzumab govitecan的不良药物事件信号. 它确定了潜在的安全问题,包括未列出的不良药物事件,强调需要保持警的临床监测.

科学领域:

药物监督药物监督药物监督
瘤学药物安全药物安全
药物不良事件分析

背景情况:

萨西图祖马布 (Sacituzumab govitecan) 是一种关键的治疗药物.
了解其不良药物事件 (ADE) 概况对于患者安全至关重要.
FAERS数据库为真实世界的安全信号检测提供了宝贵的资源.

研究的目的:

为了分析与sacituzumab govitecan相关的不良药物事件 (ADE) 信号.
识别药物的处方信息中未列出的潜在安全问题.
提供参考资料,以提高sacituzumab govitecan治疗的临床安全.

主要方法:

使用了美国食品和药物管理局不良事件报告系统 (FAERS) 数据库.
从2020年第二季度到2023年第四季度,分析了sacituzumab govitecan的不良药物事件 (ADE) 报告.
员工报告概率 (ROR) 和比例报告比率 (PRR) 是用于检测安全信号的统计方法.

主要成果:

在26个系统器官类 (SOC) 中确定了139个不良药物事件 (ADE) 信号.
最常见的ADE包括一般性疾病,注射部位疾病和胃肠道疾病.
突出显示未列出的ADE信号,如败血症,COVID-19,胆固醇病和,在某些ADE中观察到的人口变异.

结论:

虽然常见的ADEs与处方信息保持一致,但对未上市的ADEs保持警是必不可少的.
建议对实验室指标进行密切监测,以确保在sacituzumab govitecan治疗期间的患者安全.
这些发现支持西图祖马布 (sacituzumab) govitecan治疗的积极风险管理策略.

关键词:

公平的人是公平的.这就是PRRR.ROROR ROR 这是一个很好的例子.萨西图祖马布 (Sacituzumab) govitecan也可以使用.数据挖掘是数据挖掘的一个方法.

更多相关视频

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on: October 15, 2017

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

相关概念视频

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Drug Regulation

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...